tiprankstipranks
Ipsen, Genfit announce full results from pivotal Phase III ELATIVE trial
PremiumThe FlyIpsen, Genfit announce full results from pivotal Phase III ELATIVE trial
6M ago
Genfit publishes NIS4 NASH diagnostic technology data
PremiumThe Fly
Genfit publishes NIS4 NASH diagnostic technology data
8M ago
Genfit price target lowered to EUR 7 from EUR 9 at Guggenheim
PremiumThe Fly
Genfit price target lowered to EUR 7 from EUR 9 at Guggenheim
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100